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ABSTRACT
Current methods to measure the fraction of active
glycosylase molecules in a given enzyme
preparation are slow and cumbersome. Here we
report a novel assay for rapidly determining
the active fraction based on molecular accessib-
ility of a fluorescent DNA minor groove binder,
40,6-diamidino-2-phenylindole (DAPI). Several
5,6-dihydrouracil-containing (DHU) DNA substrates
were designed with sequence-dependent DAPI-
binding sites to which base excision repair glyco-
sylases were covalently trapped by reduction.
Trapped complexes impeded the association of
DAPI in a manner dependent on the enzyme used
and the location of the DAPI-binding site in relation
to the lesion. Of the sequences tested, one was
shown to give an accurate measure of the fraction
of active molecules for each enzyme tested from
both the Fpg/Nei family and HhH-GPD Nth super-
family of DNA glycosylases. The validity of the
approach was demonstrated by direct comparison
with current gel-based methods. Additionally, the
results are supported by in silico modeling based
on available crystal structures.
INTRODUCTION
All nonobligate organisms possess repair systems
responsible for the maintenance of genomic DNA in the
presence of cellular reactive oxygen species (ROS).
The majority of single base lesions generated by ROS
are abstracted by DNA glycosylases as the initial step
in the base excision repair pathway [for reviews, see (1,2)].
Mechanistically, these enzymes are classiﬁed by either
the presence of an associated AP lyase activity (bifunc-
tional), or the lack of this activity (monofunctional).
Monofunctional glycosylases cleave the glycosyl bond via
either an associative SN2 reaction utilizing an activated
water molecule or a dissociative SN1-like mechanism.
Bifunctional glycosylases employ an amine for nucleo-
philic (SN2) attack of the sugar backbone, proceeding
through a Schiﬀ base intermediate which can undergo
a b-elimination that leads to cleavage of the lesion-
containing strand [for reviews, see (3,4)]. Enzymes whose
mechanism proceed through a transient Schiﬀ base
intermediate can be trapped by the addition of a reducing
agent such as NaBH4 or NaCNBH3 [for reviews, see (5)].
Once covalently bound, trapped molecules no longer
participate in the overall reaction resulting in stable
protein–DNA complexes.
The ability to eﬃciently generate stable, covalently
bound glycosylase–DNA complexes has broad-reaching
applications and has been used extensively in the
literature. Studies utilizing this procedure include, but
are not limited to, bifunctional versus monofunctional
classiﬁcation (6–8), determination of the fraction of active
molecules in enzyme preparations (9,10), reaction rate
analyses (11,12), glycosylase activity comparisons (13–15),
iron–sulfur cluster domain analysis (16), and the char-
acterization of enzyme active-site residues (10,17–21).
A commonality among these techniques is the almost
universal requirement for separation of the trapped
complex from unbound DNA via polyacrylamide gel
electrophoresis (PAGE) prior to phosphorimager analy-
sis. It should be noted that while the characterization
of active-site residues may alternatively employ tryptic
digestion of the trapped complex in order to identify
the bound peptide (20,21), targeted mutagenesis experi-
ments require a gel-based approach (10,17–19). A gel-
based approach may be necessary in some circumstances;
for example, the determination of speciﬁc reaction
intermediates (22). However, a faster, less cumbersome
technique would be useful for the majority of situations.
The properties of 40,6-diamidino-2-phenylindole
(DAPI) have been well studied for more than 30 years,
from pH and ionic strength inﬂuences (23,24) to the
solved crystal structure of DAPI-DNA complexes (25,26).
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binds to the minor groove of AT-rich regions of double-
stranded DNA (24,27–31). Due to its unique ﬂuorescent
characteristics (31) it has been employed successfully in
various dye displacement assays (32,33). In this article,
we describe a novel approach for using DAPI as a ﬂuore-
scent reporter molecule to rapidly diﬀerentiate the number
of bound versus unbound enzymes to damaged oligonu-
cleotides following protein–DNA cross-linking. Although
the focus of this work is on determining the fraction of
active molecules in enzyme preparations, the technique is
equally applicable to the studies listed above. Any study
which necessitates analyzing the total number of trapped
enzyme–DNA moieties, and does not require discrimina-
tion of the trapped intermediates themselves, may beneﬁt
from this approach. We foresee this molecular accessibility
assay being useful in the study of numerous DNA-binding
proteins.
MATERIALS AND METHODS
DNA substrates
Oligonucleotide substrates were purchased from Midland
Certiﬁed Reagent Co. (Midland, TX) and were PAGE
puriﬁed prior to use. All gel-based comparisons were
performed with the following double-stranded substrate:
(35DHU) 50-TET-TGTCAATAGCAAGXGGAGAAGT
CAATCGTGAGTCT-30 where TET represents the
ﬂuorescent label 6-tetrachloroﬂuorescein and X¼5,6-
dihydrouracil (DHU). Molecular accessibility DAPI-
based experiments were performed with the following
double-stranded substrates: (4L) 50-GCCCCGCCAATTX
CCGCCGCCGCC-30, (5L) 50-GCCCCGCCAATTCXCC
GCCGCCGCC-30, (5R) 50-GCCCCGCCGCCCCGCCX
AATTCCGCCGCCGCC-30, and (N5R) 50-GCCCCGCC
GCCCCGCCXCAATTCCGCCGCCGCC-30 where
X¼either DHU for damaged substrates or cytosine
for non-damaged controls. All complementary strands
contained a G residue across from DHU and were
annealed in 50mM Tris-HCl (pH8.0), 50mM NaCl by
heating to 948C for 2min and slowly cooling to 48C over
the period of 1h in a Perkin Elmer DNA Thermal Cycler
480. In each case the ratio of damaged to complemen-
tary strand during annealing was 1:1.1. Note that the
DAPI-based oligonucleotides all diﬀer in location of
the AT-rich region in relation to the damaged base.
Purification of enzymes
Escherichia coli endonuclease III (EcoNth), formamido-
pyrimidine-DNA glycosylase (EcoFpg), endonuclease
VIII (EcoNei), and its human ortholog (NEIL1) were
puriﬁed by either the pET system (Novagen) or IMPACT
CN system (New England Biolabs). A detailed protocol
for cloning and expression of each of these recombinant
proteins has been previously described (34).
Trapping ofSchiff baseintermediates
EcoNth, EcoFpg, EcoNei and NEIL1 were incubated
for 30min at 378C with 100nM DHU:G-containing
substrates at ﬁnal concentrations of 50, 100, 200, 400,
800, 1200 or 1600nM, in the presence of either 50 or
100mM sodium borohydride (NaBH4) or sodium cyano-
borohydride (NaCNBH3), as described in the ﬁgures.
Borohydride compounds were dissolved fresh for each
independent experiment (one substrate and series of
enzyme dilutions) as 1.25  stocks in Milli-Q water.
Reactions were initiated by simultaneous addition of
enzyme and borohydride solution to annealed substrates
utilizing separate multi-pipettes in a 96-well format to
a ﬁnal volume of 100ml. Except for EcoFpg trapping
with sodium cyanoborohydride, the ﬁnal buﬀer for each
reaction contained 10mM Tris-HCl (pH8.0), 60mM Na
þ
and either 50mM BH 
4 orCNBH
 
3 . In the former case,
the ﬁnal buﬀer contained 10mM Tris-HCl (pH8.0),
110mM Na
þ and 100mM CNBH
 
3 .
For gel-based substrates, completed reactions
were mixed with a dye-free SDS loading buﬀer (50mM
Tris-HCl (pH6.8), 100mM dithiothreitol, 4% SDS,
10% glycerol), heated to 908C for 5min, separated by
12% SDS-PAGE, and visualized by phosphorimager
analysis (Bio-Rad Molecular Imager FX). For all other
substrates, an equal volume of 200nM DAPI in 10mM
Tris-HCl (pH 8.0) and 50mM NaCl was added
and incubated for 5min at room temperature prior to
ﬂuorescence detection. Final concentrations of the ﬂuor-
escence eﬀecting molecules at the time of detection in
these experiments were 100nM DAPI, 50nM substrate,
and 25–800nM enzyme.
Fluorescence measurements
Fluorescence readings were made on a Synergy HT Multi-
Detection Microplate Reader (BIO-TEK) using a tung-
sten-halogen lamp and 360/40 bandpass excitation ﬁlter in
conjunction with a 460/40 emission ﬁlter. Corning Half
Area, NBS treated (Nonbinding Surface), Black, 96-well
Microplates (Corning #3686) were used for all DAPI-
based experiments. The combination of enzymes, DNA
and DAPI were all shown to contribute linearly to changes
in the overall ﬂuorescence based on the range of
concentrations used; there was therefore no need to
correct for the inner ﬁlter eﬀect (data not shown).
Sodium cyanoborohydride optimization
Trapping and ﬂuorescence detection were performed
essentially as described above with 100nM 4L substrate,
200nM EcoFpg and ﬁnal buﬀer concentrations of 10mM
Tris-HCl (pH8.0), 60mM Na
þ, and 0–200mM CNBH
 
3 .
The ionic strength contribution from sodium ions was
held constant by varying the amount of the following
compounds added to each reaction: sodium chloride,
sodium cyanoborohydride, and/or tetrabutylammonium
cyanoborohydride. Fluorescence was normalized to the
ﬁrst reading and plotted as a 36 segment cubic spline curve
using Prism 4 (GraphPad Software).
Data analyses: determining theactive fraction ofmolecules
Given a suﬃciently high concentration of trapping
reagent, and a suﬃciently long incubation time,
the quantity of ES complex is related to the quantity of
1602 Nucleic Acids Research, 2007, Vol. 35, No. 5total enzyme added, ET, and total substrate added,
ST, by the equation: ES¼min(aET, bST) where a is the
active enzyme fraction, b is the active substrate fraction
(fraction cleavable), and min is the minimum function.
Furthermore, holding ST constant while varying ET can be
depicted graphically (Figure 1A) where the rising slope
is equivalent to a, the plateau is equivalent to ST b, and
the breakpoint is deﬁned by the relation: ST¼(a/b)ET.
Therefore, by varying ET from below to well above the
constant ST concentration, the active enzyme fraction can
be determined by linear regression of all points falling
below the ET breakpoint concentration. The decision to
include or exclude a given point as pre-breakpoint is
simply made so as to minimize the root-mean squared
deviation from both the pre-breakpoint regression and the
post-breakpoint best-ﬁt line with a slope of zero.
For gel-based assays, the active enzyme fraction was
determined following PhosphorImager analysis from
the relative amounts of trapped to non-trapped DNA by
the a-value method described above. For the molecular
accessibility assays, the active fraction was determined
from relative ﬂuorescence values also using the a-value
method (note that an increase in trapped enzyme
complex translates to a decrease in detected ﬂuorescence).
We hypothesized that the location of the DAPI-binding
site in relation to the trapped enzyme would aﬀect the
total detected ﬂuorescence, possibly leading to a lower
quantity of ES complex detected on some sequences. This
is depicted in Figure 1B such that the determination of
trapped complex can be described as: ES  ¼min(aET1,
bST2) where 0 1,2 1 is an accessibility parameter
and ES   ES. Complete association of DAPI, indepen-
dent of the quantity of trapped ES complex, would have
an accessibility parameter equal to 0. In contrast,
association which is perfectly dependent on the quantity
of trapped ES complex would have accessibility parameter
of 1, and therefore ES  equals ES. In this study, we show
the existence of an oligonucleotide sequence (4L) where 
approaches 1 for several DNA glycosylases from diﬀerent
phylogenetic families.
Molecular modeling
Modeling for the illustrations shown in Figure 2, and
for the results listed in Table 1 was performed using the
PyMol Molecular Graphics System (DeLano,W.L., 2002,
http://www.pymol.org) as follows: two published struc-
tures of DAPI–DNA complexes, AATT localized from
1D30.pdb (25) and the proposed ATTG shifted localiza-
tion from 432D.pdb (26,35), were molecularly super-
imposed onto the published BstNth and EcoFpg Schiﬀ
base intermediate-trapped structures 1ORN.pdb (36)
and 1K82.pdb (37), respectively. Alignment was made
using the phosphate backbone of the AATT region of
the DAPI structures and the corresponding phosphate
backbone of each enzyme–DNA structure for both
possible orientations of DAPI (due to non-symmetry of
the dye and target). The pair_ﬁt command was used to
minimize the root mean square deviation (RMSD) of each
atom in the alignment. In total, the 32-modeled structures
were ﬁt by alignment of 66, 85 or 88 atoms with RMSD
values of the ﬁt ranging from 0.765 to 1.815A ˚ .
RESULTS
Fluorescence of DAPI-boundDNA substrates
Each of the 4L, 5L, 5R and N5R substrates, along with
their non-damaged counterparts, were initially tested for
their ability to associate with DAPI and thereby aﬀect the
detected ﬂuorescence. As can be seen in Table 2, each of
the sequences showed a signiﬁcant increase in ﬂuorescence
over background. In the absence of DNA, there was only
a small increase in ﬂuorescence from the addition of
DAPI, as would be expected. The diﬀerences in ﬂuores-
cence for each of the DAPI-bound substrates are
presumably due to both sequence context and experi-
mental variations in DNA concentration. For example,
the 4L sequence is expected to have a lower total ﬂuore-
scence due to the importance of the 30 nucleotide following
the 50-AATT-30 binding sequence in regards to ﬂuores-
cence intensity (38). Due to the fact that the molecular
accessibility assay is based on relative ﬂuorescence, these
diﬀerences are inconsequential. Non-damaged substrates,
where the DHU base is replaced with cytosine, were also
tested; the ﬂuorescence levels of these substrates were
statistically equal to their damaged counterparts with the
exception of the 4L( ) context, which showed an expected
increase from the introduction of cytosine in the
50-AATTC-30 sequence.
EcoNth: DAPI accessibility emulates gel-based results
In order to validate the results of the molecular
accessibility assay, we ﬁrst determined the active fraction
of a preparation of EcoNth via traditional gel-based
methods. As shown in Figure 3A and C, the a values
were determined to be 0.199 and 0.206 for experiments
using NaBH4 and NaCNBH3 as reducing agents, respec-
tively. This corresponds to an active fraction of  20%.
The b value, though of little importance in the context
of this article, was determined to be  0.8, which is
consistent with the active fraction of substrates used in
Figure 1. Theoretical plots for active fraction determination. (A)
The quantity of ES complex formed in a standard gel-based Schiﬀ
base assay as related to the total enzyme concentration, ET, plotted by
the equation ES¼min(aET, bST), where a is the active enzyme fraction,
b the fraction of cleavable substrate and ST the total substrate added.
(B) The dashed line represents the quantity of ES  complex formed in
the DAPI molecular accessibility assay as related to the total enzyme
concentration, ET, plotted by the equation ES¼min(aET1, bST2),
where a, b and ST are as above, 0 1,2 1 is the accessibility
parameter, and ES   ES.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1603our laboratory. For each data plot, the a and b values
were calculated as depicted in Figure 1, and as described in
the materials and methods section. The total amount of
trapped complex was determined from the sum of each
shifted band in a given lane. The occurrence of multiple
gel-shifted bands is a consequence of the trapping of
intermediates along the reaction pathway and their
separation via SDS-PAGE (22). It should be noted that
the molecular accessibility assay will not distinguish
between reaction intermediates; a single ﬂuorescent read-
ing for each enzyme concentration point is generated for
all trapped complexes. For this reason, considering the
diﬃculties associated with accurately measuring pixel
intensities, the DAPI-based approach is more accurate.
Results of the molecular accessibility assay for each
of the sequence contexts and reducing agents used are
shown in Figure 3B and D. The calculated a values for the
4L, 5L and 5R sequences ranged from 0.188 to 0.243
giving an active fraction range of  19–24%, consistent
with the gel-based results. The calculated a values for
the N5R sequence were lower, giving associated active
fractions of  12% and 16%, presumably due to the ability
Figure 2. Molecular modeling of BstNth and EcoFpg with DAPI. One orientation of DAPI is shown in the predicted binding location with BstNth
and the 4L substrate (A, left) or the 5R substrate (A, right). The same orientations of DAPI are also shown with EcoFpg and the 4L substrate
(B, left) or the 5R substrate (B, right). Note the orientation of the minor groove at the DAPI-binding site in each case. See the materials and methods
section for details describing the creation of these models. See Table 1 for a summary of predicted binding locations with each enzyme and substrate
combination.
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complex. Interestingly, both the 5R and N5R sequences
showed lower then expected b values, suggesting at least
some association of DAPI with the EcoNth–5R trapped
complex as well.
In order to further elucidate the above results,
DAPI was modeled into its predicted binding locations
for each complex using a Bacillus stearothermophilus
endonuclease III trapped intermediate, as described in
the materials and methods section. Association of DAPI
with a trapped complex is modulated by two main factors,
steric hindrance between any ‘close contacts’ and orienta-
tion of the minor groove at the DAPI-binding site in
relation to the protein. Figure 2A shows two predicted
binding locations: one orientation of DAPI bound to
the 50-AATT-30 site with BstNth-4L (left) and one with
BstNth-5R (right). In the 4L sequence the minor groove
where DAPI binds is on an internal face, protected by
the enzyme. With the 5R sequence however, the minor
groove is exposed such that DAPI association can only
be inhibited by steric hindrance from close amino acids.
The top half of Table 1 summarizes the BstNth modeling
results with regard to close contacts and minor groove
location, for each predicted binding mode and orientation.
As can be seen, steric hindrance predicts that the 4L, 5L
and possibly 5R sequences should accurately determine
the active fraction. Additionally, both the 4L and 5L
sequences beneﬁt from having the minor groove where
DAPI binds in a protected location. These modeling data
support the results shown in Figure 3B and D, providing
further evidence of the validity of this assay.
EcoFpg:DAPI accessibility emulates gel-based results
Similartoabove,wealsodeterminedtheactivefractionofa
preparation of EcoFpg via traditional gel-based methods.
AsshowninFigure4AandC,theavaluesweredetermined
to be 0.121 and 0.147 depending on the reducing agent
used—corresponding to an active fraction of  13%. The
b value was again  0.8. Notably, when using 100mM
sodium cyanoborohydride as a reducing agent (Figure 4C),
a small amount of product was generated. The quantity of
product is small enough so that its inclusion or exclusion
during analysis only aﬀects the determined a value by
 1.5% (data not shown). However, the importance of
limiting product generation is paramount and is discussed
in detail below. Results of the molecular accessibility assay
for each of the sequence contexts and reducing agents used
with EcoFpg are shown in Figure 4BandD. The calculated
a values for the 4L sequence were 0.154 and 0.136 giving an
active fraction of  14%, consistent with the gel-based
results. The calculated a values for the 5R sequence were
slightly lower giving an  11% active fraction, and both the
5L and N5R sequences were signiﬁcantly lower. The
apparent b values were signiﬁcantly lower for the 5L, 5R
and N5R sequences, suggesting increased association of
DAPI with the EcoFpg–DNA trapped complex, and
therefore a smaller accessibility parameter, . The appar-
ent b value for the 4L sequence was  0.7 in these
experiments. Re-testing with EcoNth veriﬁed that the
10%dropinbvalueforthe4Lsubstratewasaccurate(data
not shown), and was presumably caused from prolonged
storage of the annealed, DHU-containing substrate at 48C.
As was done with BstNth, modeling of DAPI into the
predicted binding locations for each of the trapped
EcoFpg–DNA complexes was performed as described
in the materials and methods section and is illustrated
for two cases in Figure 2B. Once again, the 4L sequence
protects the minor groove of the drug-binding site, while
the 5R sequence exposes the 50-AATT-30 minor groove.
The bottom half of Table 1 summarizes the EcoFpg
modeling results for all predicted binding sites, for each
DNA sequence. Interestingly, only the enzyme-trapped
5R sequence predicts any steric hindrance with regard
to DAPI binding. For each of the other sequences there
is at least one orientation of DAPI with signiﬁcant
steric freedom. This includes the 4L sequence, which was
already shown to accurately determine the active fraction
of enzyme in Figure 4. This result highlights the
Table 1. Molecular modeling summary of DAPI bound to trapped
enzyme–DNA complexes. The distance in angstroms is shown for the
two closest atoms between DAPI and either BstNth or EcoFpg.
Both of the known DAPI-binding modes based on crystal structure
data, AATT and ATTG, for each of the two possible DAPI
orientations (separated by commas) are listed. The last column speciﬁes
the orientation of the minor groove where DAPI binds, in relation to
the trapped protein. See the materials and methods section for details
describing the creation of these modeling summaries.
Complex AATT ATTG Minor groove
Nth-4L 1.54, 1.70
b 1.85, 1.50
b Internal face
Nth-5L 2.36, 2.55 1.56, 2.09 Internal face
Nth-5R 2.13
b, 2.32 2.21
b, 3.10 External face
Nth-N5R 2.51, 4.41 2.96, 7.87 External face
Fpg-4L 4.97, 4.51
b 6.26, 1.58
b Internal face
Fpg-5L 5.01, 7.33 4.09, 10.8
a Internal face
Fpg-5R 0.72
b, 1.33 1.19
b, 3.23 External face
Fpg-N5R 2.54, 4.67 1.51, 7.16 External face
aexternally facing exception due to distance from protein.
borientation unlikely to occur due to the disruption of one
or more hydrogen bonds with the cleaved DNA base.
Table 2. Fluorescence of DAPI binding to double-stranded DNA. Each
double-stranded DNA, at a concentration of 50nM, was incubated
with 100nM DAPI in 10mM Tris-HCl (pH8.0) and 50mM NaCl for
5min at room temperature and ﬂuorescence was detected on a Synergy
HT Multi-Detection Microplate Reader. X¼DHU. All complementary
strands contained a G residue across from DHU. See the materials and
methods section for the complete oligonucleotide sequences.
dsDNA Subsequence DAPI FI
a
4L 50-CCAATTXC-30 þ 55.2 2.8
4L( )5 0-CCAATTCC-30 þ 62.4 2.3
5L 50-CCAATTCX-30 þ 65.9 2.6
5L( )5 0-CCAATTCC-30 þ 63.3 4.3
5R 50-CXAATTCC-30 þ 69.5 2.9
5R( )5 0-CCAATTCC-30 þ 63.7 3.4
N5R 50-XCAATTCC-30 þ 60.7 3.0
N5R( )5 0-CCAATTCC-30 þ 60.7 3.1
– n/a þ 5.0 0.4
– n/a – 2.7 0.1
aFI¼Fluorescence intensity  10
 3.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1605importance of the orientation of the minor groove at
the DAPI-binding site, and predicts the practicality of
using the 4L substrate for numerous DNA glycosylases
regardless of active site binding diﬀerences. Noting the
importance of the minor groove orientation, the modeling
data again support the molecular accessibility assay
results.
Optimizing theconcentration ofreducing agent
Optimizing the concentration of reducing agent used is
an important step for any trapping assay. It is, however,
of particular importance for accurately determining
the active fraction by DAPI association. Fully cleaved
4L substrate shows approximately one-half the maximal
ﬂuorescence compared to uncleaved substrate, due to
a higher rate of DAPI dissociation (data not shown).
The increased dissociation rate of the dye is presumably
caused by the single-strand nick 30 of the binding site.
Nevertheless, the eﬀect of this characteristic would be an
increase in apparent trapped complex in situations where
signiﬁcantly high quantities of product are allowed to
form, leading to an artiﬁcially high a value and lower
b value. To avoid this, the accessibility assay itself can be
Figure 3. EcoNth active fraction determination by gel-based and molecular accessibility assays. 0, 50, 100, 200, 400 and 800nM EcoNth was
incubated for 30min at 378C with either 100nM of 35DHU substrate (A and C) or 100nM of 4L, 5L, 5R or N5R substrates (B and D) in the
presence of either 50mM sodium borohydride (AþB) or 50mM sodium cyanoborohydride (CþD). Completed 35DHU reactions were separated by
12% SDS-PAGE; results from phosphorimager analysis with calculated a values are plotted below each gel image. Completed 4L, 5L, 5R and N5R
reactions were mixed with an equal volume of 200nM DAPI solution, incubated for 5min at room temperature, and ﬂuorescence was detected at
340nm excitation/460nm emission. Relative ﬂuorescence readings to the 0nM EcoNth sample were used to determine the concentration of ES
complex at each enzyme concentration. Error bars representing the standard deviation from three independent experiments are shown on all points
where the error was larger than the body of the symbol. See the materials and methods section for further details of experimental design and analysis.
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agent. Figure 5 shows a typical optimization experi-
ment where sodium cyanoborohydride concentration
is optimized for one concentration of EcoFpg. As the
concentration of reducing agent initially increases we see
a substantial drop in the apparent concentration of
trapped complex. This drop is expected based on the
fact that a higher percentage of active enzyme molecules
are being trapped before they are able to turnover
a signiﬁcant amount of product. Beyond 50mM
NaCNBH3 we see that there is an inﬂection point in the
graph where increases in reducing agent concentration
more eﬃciently lead to trapped complexes while limiting
the production of product. The ﬁnal inﬂection point
at  100mM NaCNBH3 is the optimal concentration for
this reducing agent with this speciﬁc enzyme; higher
concentrations prove inhibitory. The magnitude of each
inﬂection point is speciﬁc to the enzyme used and to
the active fraction of the enzyme in the preparation
being tested. Finally, one should note the importance of
maintaining ionic strength even at higher reducing agent
concentrations, by using compounds such as tetrabuty-
lammonium cyanoborohydride.
As shown in Figure 5, the optimal cyanoborohydride
concentration was determined to be 100mM. This concen-
tration was used for the experiments shown in Figure 4C,
Figure 4. EcoFpg active fraction determination by gel-based and molecular accessibility assays. 0, 200, 400, 800, 1200 and 1600nM EcoFpg was
incubated for 30min at 378C with either 100nM of 35DHU substrate (A and C) or 100nM of 4L, 5L, 5R or N5R substrates (B and D) in the
presence of either 50mM sodium borohydride (AþB) or 100mM sodium cyanoborohydride (CþD). Completed 35DHU reactions were separated
by 12% SDS-PAGE; results from PhosphorImager analysis with calculated a values are plotted below each gel image. Completed 4L, 5L, 5R and
N5R reactions were mixed with an equal volume of 200nM DAPI solution, incubated for 5min at room temperature, and ﬂuorescence was detected
at 340nm excitation/460nm emission. Relative ﬂuorescence readings to the 0nM EcoFpg sample were used to determine the concentration of ES
complex at each enzyme concentration. Error bars representing the standard deviation from three independent experiments are shown on all points
where the error was larger than the body of the symbol. See the materials and methods section for further details of experimental design and analysis.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1607yet a small amount of product was still detected.
Therefore, the use of a stronger reducing agent like
NaBH4 is recommended. While one could use NaBH4
exclusively, the concurrent use of NaCNBH3 provides a
beneﬁcial level of redundancy and comparisons between
the two provide good evidence concerning the generation
of a signiﬁcant quantity of product.
DAPIaccessibility with differentenzyme preparations
To demonstrate the use of the accessibility assay with
enzyme preparations having signiﬁcantly diﬀerent activ-
ities, two additional preparations were analyzed with the
4L substrate: an EcoNei puriﬁcation known to have little
activity and a more recent NEIL1 puriﬁcation with
good activity. Two concentrations were chosen for each,
reﬂecting the prior knowledge of activity levels, and the
desire to determine only the a values with a minimal
amount of enzyme. Figure 6 shows results from the assay,
and gives further detail into the calculation of ES
concentration based on relative ﬂuorescence. The accessi-
bility assay was able to accurately determine the a value
for both the EcoNei preparation, with less than 5%
activity, and the NEIL1 preparation, with over 50%
activity. Each of these was veriﬁed to be correct by
traditional gel-based methods (data not shown).
DISCUSSION
In this article, we have described a novel approach to
rapidly diﬀerentiate the number of bound versus unbound
enzymes to damaged oligonucleotides following Schiﬀ
base trapping. Though the assay described focused on
determining the fraction of active molecules in enzyme
preparations, the technique itself should be applicable to
any study which necessitates quantifying the total number
of bound enzyme–DNA moieties. Previous approaches
have been limited to either a traditional PAGE analysis
or to the analysis of speciﬁc enzymes; for example, activity
determination via the burst phase for glycosylases with
slow product release (39).
For either the gel-based or DAPI-based approach,
the crucial step is the ability to form trapped enzyme–
DNA complexes. Though Schiﬀ base formation is
typically limited to bifunctional glycosylases, some mono-
functional glycosylases may also be trapped by borohy-
dride reduction (40,41). For monofunctional glycosylases
which cannot be trapped via borohydride reduction,
alternative trapping agents might prove useful. The use
of 2-deoxyribonolactone and oxanine are both promising
covalent trapping agents for various bifunctional and
monofunctional glycosylases (42–45). The use of these
compounds for active fraction analysis is currently being
investigated.
Throughout this study a single damaged nucleotide,
DHU, was used for all substrates. While this is adequate
for comparisons made as a proof of concept, accurate
determination of the active fraction of numerous
enzymes requires additional substrates. For example, for
accurate determination of the active fraction of EcoFpg,
7,8-dihydro-8-oxoguanine (8-oxoG) should be used based
on the greater aﬃnity for that damage. Some damaged
nucleotides, such as 5-formyluracil, would be inappro-
priate for the activity determination of certain enzymes,
due to their low aﬃnity for the damage (13). The ‘best’
substrate for a given enzyme, based on prior knowledge,
should always be used for accurate activity calculations.
For previously uncharacterized enzymes, analysis of
numerous substrates is required. Strong reducing agents,
such as NaBH4, should not be used in combination with
damages which are extremely prone to reduction such as
AP sites. In these cases, the use of NaCNBH3, where the
Figure 5. Reducing agent optimization with the molecular accessibility
assay. EcoFpg, at a concentration of 200nM, was incubated for 30 min
at 378C with 100nM 4L substrate in the presence of 0–200mM
cyanoborohydride ion. Tetrabutylammonium cyanoborohydride was
used at high concentrations to maintain similar ionic strengths in each
reaction. Fluorescence was normalized to the ﬁrst reading and plotted
as inverse relative ﬂuorescence versus CNBH
 
3 concentration on a cubic
spline curve. See the materials and methods section for further details.
Figure 6. NEIL1 and EcoNei active fraction determination by the
molecular accessibility assay. NEIL1, at concentrations of 50 and
100nM, and EcoNei, at concentrations of 100 and 200nM, were
incubated with 100nM 4L substrate in the presence of 50 mM sodium
borohydride. Completed reactions were mixed with an equal volume of
200nM DAPI solution, incubated for 5min at room temperature, and
ﬂuorescence was detected at 340nm excitation/460nm emission.
Relative ﬂuorescence readings to the 0nM enzyme sample were used
to determine the concentration of ES complex using the equation
ES¼ST (1 RF) where RF is the relative ﬂuorescence at each given
enzyme concentration, as shown in the table (left). Plotted ES
concentrations (right) were used to determine the a values by linear
regression. Activity is simply deﬁned as the percentage of determined a
values (100 a). NEIL1, solid circles; EcoNei, open circles.
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is required (22). Regardless, it should also be noted
that partial destruction of the substrate via reduction will
not aﬀect calculation of the a value, only the b value will
be aﬀected. With either the gel-based or DAPI-based
methods, a strong reducing environment may possibly
lead to inactivation of some enzyme molecules.
Nonetheless, it is unlikely that both NaBH4 and
NaCNBH3 will show the same rate of inactivation due
to the inherent diﬀerences in their rate of reduction.
A side-by-side test with both reducing agents (as was
done in Figures 3 and 4) is arguably a valid control for
demonstrating the lack of enzyme inactivation.
The accessibility, and inaccessibility, of the reporter dye
to its binding site is obviously a hallmark of this assay.
The preference of DNA minor groove-binding drugs for
AT-rich sequences is thought to be primarily due to the
narrow minor groove width which inﬂuences hydrogen
bonding and van der Waals’ interactions, and interrela-
tionships of the positively charged amino ends of the
drugs with the more negatively charged minor groove of
AT sequences (46–50). The choice to use DAPI was
primarily based on its well-known binding properties, ease
of use with our current ﬂuorimeter and the success of its
use in other ﬂuorescence assays (32,33). That said, other
minor groove-binding dyes may prove useful in accessi-
bility assays, notably ones with a larger minor groove
footprint.
Comparing results of the molecular accessibility assay
with the modeling results presented in Table 1, a number
of insights can be drawn. Notably, when either EcoNth
or EcoFpg was trapped with the 5R substrate, a lower
accessibility parameter, , was apparent. In each case,
particularly with EcoFpg, the only predicted binding
mode of DAPI with a greater than 3A ˚ distance from the
enzyme is the ATTG-binding mode. When this structure
was published, the authors were unable to unequivocally
state that this AT/GC binding mode was sequence speciﬁc
and not simply an artifact of crystal packing (26).
The data presented here provide further evidence of
alternative DAPI-binding modes, and does not rule out
the possibility of the AT/GC association. No claims can
be made, however, on the preference of one binding site
over another.
As mentioned above, drug association may be modu-
lated by either steric hindrance from the enzyme at the
predicted DAPI-binding site and/or protection of the
DAPI-binding site by orientation of the minor groove in
relation to the protein. The fact that EcoFpg and the
4L substrate can accurately determine the active enzyme
fraction (Figure 4B and D), and that both predicted
binding modes for the EcoFpg–4L trapped complex have
at least one orientation of DAPI which is not sterically
hindered (Table 1), suggests that orientation of the DAPI-
binding site is the more important contributor in
modulating association. It should be noted that although
the 5L substrate is generally classiﬁed as ‘internally
facing’, one orientation of DAPI in the ATTG binding
mode with trapped EcoFpg is externally facing due to the
distance of DAPI from the enzyme. It is presumably
for this reason that the 5L substrate is unable to accurately
determine the active fraction with EcoFpg, since the
other predicted binding conﬁgurations have internally
facing DAPI-binding sites.
In this study, we have demonstrated a rapid, ﬂuores-
cence-based approach for determining the number of
bound versus unbound BER enzymes to damaged
oligonucleotides following Schiﬀ base trapping. The use
of the 4L sequence context correctly determines enzyme
activity from relative ﬂuorescence calculations (no cali-
bration necessary), for numerous DNA glycosylases from
multiple phylogenetic families. The total experimental
time is reduced from the standard 1–2 days using a
traditional gel-based method, to under 1h for the DAPI-
based method. In a 96-well microplate format, the number
of concurrent samples which can be tested also scales well.
Additionally, neither radioactive nor ﬂuorescent labels are
required for substrate DNA. These beneﬁts have allowed
us to undertake frequent activity monitoring of enzyme
stocks in our laboratory. One enzyme in particular has
been found to drop from over 80% activity to 20% within
a matter of weeks after initial puriﬁcation. The testing
of numerous optimized storage conditions can now be
accomplished in minimal time. In conclusion, the mole-
cular accessibility assay, speciﬁcally in conjunction with
DAPI and the 4L substrate, should be useful in the study
of numerous DNA-binding proteins.
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